hardman - you need to look at this share from the perspective of...

hardman - you need to look at this share from the perspective of an IPO investor, this placement brings total shares to 257M and 64M options which effectively dilutes the 97M IPO shares by two thirds plus the 20c IPO price has lost 9/10 of its value. Thus every $1000 IPO dollars is now only $66.

As for your Dr Mohamed who had less than 3M shares prior to the rights issue, how did he get 27M shares when his entitlement was less than 1M.

Now Carter has bought stock I would be very suspicious if there was sudden announcement of a major sales contract.

What I am bitter about is that Colltech should have been selling cosmetic grade collagen as soon as it received the required approvals 18 months ago and we would never had this dilution plus we would all be 'in the money'.